| [1] |
Tuo JY, Zhang M, Zheng RS, et al. Report of incidence and mortality of gallbladder cancer in China, 2014[J]. Chin J Oncol, 2018, 40(12): 894-899.
|
| [2] |
Kaser SA, Mattiello D, Maurer CA. Distant metastasis in colorectal cancer is a risk factor for anastomotic leakage[J].Annals of Surgical Oncology, 2016, 23(3): 888-893.
|
| [3] |
Al-Asfoor A, Fedorowicz Z, Lodge M. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases[J]. Cochrane Database Syst Rev, 2008(2): Cd006039.
|
| [4] |
Mayo SC, Pulitano C, Marques H, et al. Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis[J]. Journal of the American College of Surgeons, 2013, 216(4): 707-716, discussion 16-18.
|
| [5] |
中华医学会外科分会胃肠外科学组, 中华医学会外科分会结直肠外科学组 中国抗癌协会大肠癌专业委员会,等. 结直肠癌肝转移诊断和综合治疗指南（V2018）[J].中华胃肠外科杂志, 2018, 21(6): 601-626.
|
| [6] |
Chua TC, Saxena A, Liauw W, et al. Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases-a systematic review[J]. Euro J Cancer (Oxford, England: 1990), 2012, 48(12): 1757-1765.
|
| [7] |
Pulitano C, Bodingbauer M, Aldrighetti L, et al. Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection[J]. Ann Surg Oncol, 2012, 19(2): 435-442.
|
| [8] |
Fukami Y, Kaneoka Y, Maeda A, et al. Simultaneous resection for colorectal cancer and synchronous liver metastases[J]. Surgery Today, 2016, 46(2): 176-182.
|
| [9] |
Reddy SK, Pawlik TM, Zorzi D, et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis[J]. Ann Surg Oncol, 2007, 14(12): 3481-3491.
|
| [10] |
Capussotti L, Ferrero A, Vigano L, et al. Major liver resections synchronous with colorectal surgery[J]. Ann Surg Oncol, 2007, 14(1): 195-201.
|
| [11] |
Yin Z, Liu C, Chen Y, et al. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): Simultaneous or delayed?[J]. Hepatology (Baltimore, Md), 2013, 57(6): 2346-2357.
|
| [12] |
Gavriilidis P, Sutcliffe RP, Hodson J, et al. Simultaneous versus delayed hepatectomy for synchronous colorectal liver metastases: a systematic review and meta-analysis[J]. HPB: the Official Journal of the International Hepato Pancreato Biliary Association, 2018, 20(1): 11-19.
|
| [13] |
Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival[J]. Ann Surg, 2004, 240(4): 644-657, discussion 57-58.
|
| [14] |
Adam R, De Gramont A, Figueras J, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus[J]. The Oncologist, 2012, 17(10): 1225-1239.
|
| [15] |
Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial[J]. Lancet (London, England), 2008, 371(9617): 1007-1016.
|
| [16] |
Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases[J]. Ann Surg, 1999, 230(3): 309-318, discussion 18-21.
|
| [17] |
Ayez N, van der Stok EP, Grunhagen DJ, et al. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator[J]. Europ J Surg Oncol: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, 41(7): 859-867.
|
| [18] |
Liu W, Zhou JG, Sun Y, et al. The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis[J]. Oncotarget, 2016, 7(24): 37277-37287.
|
| [19] |
Cui CH, Huang SX, Qi J, et al. Neoadjuvant chemotherapy (NCT) plus targeted agents versus NCT alone in colorectal liver metastases patients: A systematic review and meta-analysis[J]. Oncotarget, 2015, 6(41): 44005-44018.
|
| [20] |
Uetake H, Yasuno M, Ishiguro M, et al. A multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808)[J]. Ann Surg Oncol, 2015, 22(3): 908-915.
|
| [21] |
Ye LC, Liu TS, Ren L, et al. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases[J]. J Clin Oncol: Official Journal of the American Society of Clinical Oncology, 2013, 31(16): 1931-1938.
|
| [22] |
Primrose J, Falk S, Finch-Jones M, et al. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial[J]. The Lancet Oncology, 2014, 15(6): 601-611.
|
| [23] |
Wang L, Sun Y, Zhao B, et al. Chemotherapy plus targeted drugs in conversion therapy for potentially resectable colorectal liver metastases: a meta-analysis[J]. Oncotarget, 2016, 7(34): 55732-55740.
|
| [24] |
Imai K, Allard MA, Benitez CC, et al. Early recurrence after hepatectomy for colorectal liver metastases: What optimal definition and what predictive factors?[J]. The Oncologist, 2016, 21(7): 887-894.
|
| [25] |
Takorov I, Belev N, Lukanova T, et al. Laparoscopic combined colorectal and liver resections for primary colorectal cancer with synchronous liver metastases[J]. Annals of Hepato-Biliary-Pancreatic Surgery, 2016, 20(4): 167-172.
|
| [26] |
Xu X, Guo Y, Chen G, et al. Laparoscopic resections of colorectal cancer and synchronous liver metastases: a case controlled study[J]. Minimally Invasive Therapy & Allied Technologies: MITAT: Official Journal of the Society for Minimally Invasive Therapy, 2018, 27(4): 209-216.
|
| [27] |
Abu Hilal M, Underwood T, Zuccaro M, et al. Short- and medium-term results of totally laparoscopic resection for colorectal liver metastases[J]. Bri J Surg, 2010, 97(6): 927-933.
|
| [28] |
Nguyen KT, Laurent A, Dagher I, et al. Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes[J]. Ann Surg, 2009, 250(5): 842-848.
|
| [29] |
Yue M, Li S, Yan G, et al. Short- and long-term outcomes of laparoscopic hepatectomy for colorectal liver metastases in elderly patients[J]. Cancer Management and Research, 2018, 10: 2581-2587.
|
| [30] |
Chen YW, Huang MT, Chang TC. Long term outcomes of simultaneous laparoscopic versus open resection for colorectal cancer with synchronous liver metastases[J]. Asian Journal of Surgery, 2019, 42(1): 217-223.
|
| [31] |
Silberhumer GR, Paty PB, Denton B, et al. Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer[J]. Surgery, 2016, 160(1): 67-73.
|
| [32] |
Moris D, Tsilimigras DI, Machairas N, et al. Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review[J]. J Surg Oncol, 2019, 119(1): 30-39.
|
| [33] |
Gomez Dorronsoro ML, Vera R, Ortega L, et al. Recommendations of a group of experts for the pathological assessment of tumour regression of liver metastases of colorectal cancer and damage of non-tumour liver tissue after neoadjuvant therapy[J]. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2014, 16(3): 234-242.
|
| [34] |
Karanicolas PJ, Metrakos P, Chan K, et al. Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement[J]. Current Oncology (Toronto, Ont), 2014, 21(1): e129-136.
|